Stress overflow and urger incontinence,, pathophysiology,causes,features, diagnostic work and management...tell shortly
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
I now have comprehensive content from Berek & Novak's Gynecology covering pathophysiology, causes, features, diagnosis, and management of both stress and urge (and overflow) urinary incontinence. Let me compile the full answer.
Urinary Incontinence: Stress, Urge, and Overflow
(Source: Berek & Novak's Gynecology; Campbell-Walsh Wein Urology)
1. STRESS URINARY INCONTINENCE (SUI)
Pathophysiology
SUI occurs when urethral closure pressure is overcome by a sudden rise in intra-abdominal pressure, in the absence of a detrusor contraction. Two mechanisms:
- Urethral hypermobility - loss of pelvic floor support causes the urethra/bladder neck to descend on exertion, disrupting the pressure transmission mechanism (normally, abdominal pressure is equally transmitted to both bladder and urethra)
- Intrinsic sphincter deficiency (ISD) - the urethral sphincter itself is weak/damaged (e.g., after pelvic surgery or radiation), so it cannot maintain closure even at rest
Causes / Risk Factors
| Factor | Notes |
|---|---|
| Vaginal delivery / parity | 2x increased risk vs. cesarean |
| Obesity | Chronically elevated intra-abdominal pressure |
| Age < 50 (peaks 5th decade) | Linked to childbirth history |
| Chronic cough / COPD / smoking | Repeated Valsalva |
| Pelvic surgery | Urethral sphincter trauma |
| White race | Higher prevalence than other races |
| Estrogen deficiency | Urethral mucosal atrophy |
Clinical Features
- Leakage with coughing, sneezing, laughing, lifting, exercising
- No urgency preceding the leak
- Small-to-moderate volume leakage
- Positive stress test (cough test) with visible urine loss at the urethral meatus
2. URGENCY URINARY INCONTINENCE (UUI)
Pathophysiology
UUI is mostly idiopathic. It is often associated with overactive bladder (OAB). Proposed mechanisms:
- Detrusor overactivity - involuntary detrusor contractions during the filling phase (myogenic or neurogenic origin)
- Urothelial/afferent dysfunction - abnormal sensory signaling from the bladder wall (increased ATP/acetylcholine release from urothelium stimulates afferent nerves, triggering premature micturition reflex)
- Neurogenic causes - upper motor neuron lesions (stroke, Parkinson's, MS, spinal cord injury) remove cortical inhibition of the micturition reflex
- Bladder outlet obstruction can trigger secondary detrusor overactivity
Causes / Risk Factors
- Idiopathic (most common)
- Neurological disease: stroke, MS, Parkinson's, spinal cord injury
- Bladder irritants: UTI, bladder stones, bladder cancer, radiation cystitis
- Age > 50 (strong predictor)
- Black race (higher risk than white)
- Obesity, diabetes
- Medications: diuretics, caffeine
Clinical Features
- Sudden, compelling urge to urinate that cannot be deferred
- Leakage before reaching the toilet
- Frequency (>8 voids/day) and nocturia
- Often associated with OAB syndrome ("wet OAB")
- Larger volume losses than SUI
- May be triggered by running water, key-in-lock, cold exposure
3. OVERFLOW INCONTINENCE
Pathophysiology
Results from chronic urinary retention with an overdistended bladder that "overflows." Two main mechanisms:
- Underactive detrusor (detrusor acontractility) - poor/absent bladder contractions; bladder fills beyond capacity
- Bladder outlet obstruction - outflow blocked (e.g., pelvic organ prolapse, urethral stricture, post-surgical), leading to high residual urine and overflow
Causes
- Neurogenic: diabetic cystopathy, sacral cord lesions (S2-S4), multiple sclerosis
- Pharmacologic: anticholinergics, opioids, alpha-agonists
- Outflow obstruction: severe pelvic organ prolapse, urethral stricture, post-surgical scarring
- Constipation (extrinsic compression)
- Postpartum urinary retention
Clinical Features
- Constant dribbling of urine or frequent small-volume leakage
- Sensation of incomplete bladder emptying
- Weak urinary stream
- High post-void residual (PVR) volume (> 200 mL)
- No or minimal urgency sensation
- Distended, palpable bladder on exam
4. DIAGNOSTIC WORKUP
Step 1 - History & Symptom Assessment
- Type, frequency, volume, and triggers of leakage
- Fluid intake, voiding diary (3-day bladder diary)
- Associated symptoms: dysuria, hematuria, prolapse, neurological symptoms
- Medications review
- Impact on quality of life (ICIQ-SF questionnaire)
Step 2 - Physical Examination
- BMI, mobility assessment
- Abdominal exam (distended bladder in overflow)
- Pelvic exam: pelvic organ prolapse, urethral mobility, atrophy
- Neurological: perineal sensation, anal tone, bulbocavernosus reflex
- Cough stress test - with full bladder, ask patient to cough; observe urethral meatus
Step 3 - Basic Tests
| Test | Purpose |
|---|---|
| Urinalysis + culture | Exclude UTI, hematuria |
| Post-void residual (PVR) | By ultrasound or catheter; >150-200 mL suggests overflow/retention |
| Renal function | If obstruction suspected |
| Blood glucose | Screen for diabetic neuropathy |
Step 4 - Urodynamic Studies (when needed)
- Cystometry (filling cystometry) - detects detrusor overactivity (UUI), reduced compliance, bladder capacity
- Urethral pressure profilometry - measures urethral sphincter function (ISD in SUI)
- Uroflowmetry + PVR - voiding dysfunction/overflow
- Video-urodynamics - gold standard when diagnosis is unclear or before surgery
- Pad test - quantifies leakage severity (1-hr or 24-hr)
- Cystoscopy - if hematuria, suspected bladder lesion, interstitial cystitis
5. MANAGEMENT
Stress Urinary Incontinence
Conservative (first-line):
- Pelvic floor muscle training (Kegel exercises) - 8-12 week program; most effective conservative treatment
- Weight loss - if BMI > 25
- Bladder training - scheduled voiding
- Pessary (urethral support device) - mechanical support, especially if prolapse coexists
- Topical estrogen - for atrophic urethritis
Pharmacological:
- Duloxetine (SNRI) - increases urethral sphincter tone via pudendal nerve; moderate efficacy; limited by side effects (nausea)
- Off-label: alpha-agonists (pseudoephedrine) - mild benefit
Surgical (definitive):
- Mid-urethral sling (tension-free vaginal tape - TVT, or transobturator tape - TOT) - most common and effective surgery; >80-90% cure rates
- Burch colposuspension - open/laparoscopic retropubic suspension
- Periurethral bulking agents (collagen, Macroplastique) - for ISD in frail/high-risk patients; less durable
Urgency Urinary Incontinence / OAB
Behavioral (first-line):
- Bladder training - progressive voiding intervals; suppress urgency by cortical inhibition
- Urgency suppression techniques
- Fluid management, caffeine/alcohol reduction
- Weight loss
Pharmacological (second-line):
- Antimuscarinics - oxybutynin, tolterodine, solifenacin, trospium, fesoterodine; reduce detrusor overactivity (block M2/M3 receptors). Side effects: dry mouth, constipation, cognitive effects (avoid in elderly)
- Beta-3 agonist (mirabegron) - relaxes detrusor via beta-3 adrenoceptors; preferred in elderly (no anticholinergic SE)
- Combination antimuscarinics + mirabegron for refractory cases
Third-line (refractory):
- OnabotulinumtoxinA (Botox) intradetrusor injection - 100-200 units; inhibits acetylcholine release; effective for 6-12 months; risk of urinary retention
- Posterior tibial nerve stimulation (PTNS) - weekly outpatient percutaneous sessions
- Sacral neuromodulation (InterStim) - implanted device modulates sacral reflex arc; highly effective for refractory OAB/UUI
Overflow Incontinence
- Treat the underlying cause (discontinue offending medications, relieve obstruction, manage prolapse)
- Clean intermittent self-catheterization (CISC) - primary management for underactive detrusor or high PVR
- Indwelling urethral catheter - short-term or when CISC not feasible
- Alpha-blockers (tamsulosin) - if bladder neck obstruction
- Bethanechol (cholinergic) - rarely used; to stimulate detrusor in acontractility
Quick Comparison Summary
| Feature | Stress UI | Urgency UI | Overflow UI |
|---|---|---|---|
| Trigger | Cough, sneeze, exercise | Urge, cannot defer | Continuous dribble |
| Mechanism | Urethral weakness/hypermobility | Detrusor overactivity | Overdistended bladder |
| Volume | Small | Large | Small, constant |
| PVR | Normal | Normal | HIGH |
| Key Rx | Sling / PFMT | Anticholinergics / Botox | CISC / treat cause |
Sources: Berek & Novak's Gynecology, pp. 1516-1545; Campbell-Walsh Wein Urology
This is a shared conversation. Sign in to Orris to start your own chat.